Page 1 of Clinical Trials for growth hormone receptor antagonist, 218 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Last Updated: September 23, 2010
Condition(s): Acromegaly; Heart Failure; Hypertrophy, Left Ventricular
2
Completed
Acute Application of Pegvisomant and Octreotide in Acromegaly
Last Updated: March 31, 2008
Condition(s): Acromegaly
3
Completed
Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content
Last Updated: August 11, 2008
Condition(s): Metabolism; Fatty Liver
4
Completed
Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients
Last Updated: March 24, 2008
Condition(s): Quality of Life; Acromegaly
5
Completed
Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients
Last Updated: April 20, 2011
Condition(s): Acromegaly
6
Terminated
Effect of Pegvisomant on GH/IGF-I Relationship in GHD
Last Updated: May 2, 2007
Condition(s): Severe Adult Growth Hormone Deficiency
7
Completed
Long-Term Effect and Efficacy of Growth Hormone Replacement Therapy in Chronic Heart Failure
Last Updated: April 12, 2012
Condition(s): Growth Hormone Deficiency; Chronic Heart Failure
8
Completed
D3-Growth Hormone Receptor Polymorphism and Total Effect of Recombinant Human Growth Hormone on Growth in Girls With Turner Syndrome
Last Updated: March 2, 2007
Condition(s): Turner Syndrome; Growth
9
Completed
rhGH Therapy on Hepatic Drug Metabolism
Last Updated: August 4, 2011
Condition(s): Growth Hormone Deficiency, Dwarfism
10
Recruiting
Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
Last Updated: March 13, 2012
Condition(s): Burns
11
Completed
Growth Hormone Signaling in Vivo in Humans
Last Updated: August 6, 2007
Condition(s): Intracellular Signaling Peptides and Proteins
12
Recruiting
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
Last Updated: February 27, 2007
Condition(s): Migraine Headache
13
Terminated
Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease
Last Updated: March 24, 2008
Condition(s): Chronic Kidney Disease
14
Completed
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases
Last Updated: March 9, 2012
Condition(s): Prostate Cancer
15
Recruiting
Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
Last Updated: January 3, 2011
Condition(s): Prader-willi Syndrome
16
Terminated
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer
Last Updated: February 14, 2011
Condition(s): Prostate Cancer
17
Completed
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer
Last Updated: July 18, 2011
Condition(s): Prostate Cancer
18
Active, not recruiting
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
Last Updated: July 31, 2010
Condition(s): Breast Cancer
19
Active, not recruiting
Tipifarnib and Fulvestrant as Second-Line Therapy in Treating Postmenopausal Women With Hormone Receptor-Positive Inoperable Locally Advanced or Metastatic Breast Cancer With Progressive Disease After Previous First-Line Endocrine Therapy
Last Updated: June 20, 2009
Condition(s): Breast Cancer
20
Completed
Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates
Last Updated: May 2, 2012
Condition(s): Growth Hormone Deficiency

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=growth+hormone+receptor+antagonist

Page 1 of Clinical Trials for growth hormone receptor antagonist, 218 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About